Clinical trial
Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety…
NCT00282828 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00282828 |
|---|---|
| Title | Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder |
| Official title | Improving Outcomes in Pharmacotherapy of Social Phobia |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Social Phobia |
| Intervention type | Drug |
| Interventions | Sertraline, Venlafaxine, Placebo, Clonazepam |
| Enrollment | 397 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Jan 27, 2006 |
| Last update posted | Oct 14, 2013 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: